164 related articles for article (PubMed ID: 38761264)
1. Pediatric-type low-grade gliomas in adolescents and young adults-challenges and emerging paradigms.
Bennett J; Yeo KK; Tabori U; Hawkins C; Lim-Fat MJ
Childs Nerv Syst; 2024 May; ():. PubMed ID: 38761264
[TBL] [Abstract][Full Text] [Related]
2. Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
Fangusaro J; Jones DT; Packer RJ; Gutmann DH; Milde T; Witt O; Mueller S; Fisher MJ; Hansford JR; Tabori U; Hargrave D; Bandopadhayay P
Neuro Oncol; 2024 Jan; 26(1):25-37. PubMed ID: 37944912
[TBL] [Abstract][Full Text] [Related]
3. LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
van Tilburg CM; Kilburn LB; Perreault S; Schmidt R; Azizi AA; Cruz-Martínez O; Zápotocký M; Scheinemann K; Meeteren AYNS; Sehested A; Opocher E; Driever PH; Avula S; Ziegler DS; Capper D; Koch A; Sahm F; Qiu J; Tsao LP; Blackman SC; Manley P; Milde T; Witt R; Jones DTW; Hargrave D; Witt O
BMC Cancer; 2024 Jan; 24(1):147. PubMed ID: 38291372
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Pediatric Low-Grade Gliomas.
Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
[TBL] [Abstract][Full Text] [Related]
5. Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults.
Weiser A; Sanchez Bergman A; Machaalani C; Bennett J; Roth P; Reimann RR; Nazarian J; Guerreiro Stucklin AS
Front Oncol; 2023; 13():1254645. PubMed ID: 37781183
[TBL] [Abstract][Full Text] [Related]
6. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
Ryall S; Zapotocky M; Fukuoka K; Nobre L; Guerreiro Stucklin A; Bennett J; Siddaway R; Li C; Pajovic S; Arnoldo A; Kowalski PE; Johnson M; Sheth J; Lassaletta A; Tatevossian RG; Orisme W; Qaddoumi I; Surrey LF; Li MM; Waanders AJ; Gilheeney S; Rosenblum M; Bale T; Tsang DS; Laperriere N; Kulkarni A; Ibrahim GM; Drake J; Dirks P; Taylor MD; Rutka JT; Laughlin S; Shroff M; Shago M; Hazrati LN; D'Arcy C; Ramaswamy V; Bartels U; Huang A; Bouffet E; Karajannis MA; Santi M; Ellison DW; Tabori U; Hawkins C
Cancer Cell; 2020 Apr; 37(4):569-583.e5. PubMed ID: 32289278
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database.
Bandopadhayay P; Bergthold G; London WB; Goumnerova LC; Morales La Madrid A; Marcus KJ; Guo D; Ullrich NJ; Robison NJ; Chi SN; Beroukhim R; Kieran MW; Manley PE
Pediatr Blood Cancer; 2014 Jul; 61(7):1173-9. PubMed ID: 24482038
[TBL] [Abstract][Full Text] [Related]
8. The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies.
Guerreiro Stucklin AS; Tabori U; Grotzer MA
Neuropediatrics; 2016 Apr; 47(2):70-83. PubMed ID: 26764564
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
Fukuoka K; Mamatjan Y; Tatevossian R; Zapotocky M; Ryall S; Stucklin AG; Bennett J; Nobre LF; Arnoldo A; Luu B; Wen J; Zhu K; Leon A; Torti D; Pugh TJ; Hazrati LN; Laperriere N; Drake J; Rutka JT; Dirks P; Kulkarni AV; Taylor MD; Bartels U; Huang A; Zadeh G; Aldape K; Ramaswamy V; Bouffet E; Snuderl M; Ellison D; Hawkins C; Tabori U
Neuro Oncol; 2020 Oct; 22(10):1474-1483. PubMed ID: 32242226
[TBL] [Abstract][Full Text] [Related]
10. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
11. Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment.
Tsai JW; Choi JJ; Ouaalam H; Murillo EA; Yeo KK; Vogelzang J; Sousa C; Woods JK; Ligon KL; Warfield SK; Bandopadhayay P; Cooney TM
Neurooncol Adv; 2023; 5(1):vdac182. PubMed ID: 36926246
[TBL] [Abstract][Full Text] [Related]
12. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.
Fernández MB; Alonso VP
Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
Tateishi K; Nakamura T; Yamamoto T
Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults.
Diwanji TP; Engelman A; Snider JW; Mohindra P
Adolesc Health Med Ther; 2017; 8():99-113. PubMed ID: 28989289
[TBL] [Abstract][Full Text] [Related]
15. The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.
Sigaud R; Rösch L; Gatzweiler C; Benzel J; von Soosten L; Peterziel H; Selt F; Najafi S; Ayhan S; Gerloff XF; Hofmann N; Büdenbender I; Schmitt L; Foerster KI; Burhenne J; Haefeli WE; Korshunov A; Sahm F; van Tilburg CM; Jones DTW; Pfister SM; Knoerzer D; Kreider BL; Sauter M; Pajtler KW; Zuckermann M; Oehme I; Witt O; Milde T
Neuro Oncol; 2023 Mar; 25(3):566-579. PubMed ID: 35882450
[TBL] [Abstract][Full Text] [Related]
16. A Molecular Update and Review of Current Trials in Paediatric Low-Grade Gliomas.
Al-Jilaihawi S; Lowis S
Pediatr Neurosurg; 2023; 58(5):290-298. PubMed ID: 37604126
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N
BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes of pediatric intracranial gliomas: results from single center's 226 cases and corroborated with SEER database.
Chen Z; Guo Z; Wang J; Cao D; Xu Y; Dong F; Wan F
Childs Nerv Syst; 2023 Mar; 39(3):593-601. PubMed ID: 36662273
[TBL] [Abstract][Full Text] [Related]
19. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites.
Solano-Páez P; Fonseca A; Baroni LV; Amayiri N; Somarriba MP; Freytes C; Quiroga E; Rivero M; Márquez J; Lassaletta Á; Bouffet E
J Neurooncol; 2022 Mar; 157(1):147-156. PubMed ID: 35122583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
